Spaces:
Running
Running
File size: 73,651 Bytes
9754890 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 |
{
"cells": [
{
"cell_type": "code",
"execution_count": 1,
"metadata": {},
"outputs": [],
"source": [
"import pandas as pd"
]
},
{
"cell_type": "code",
"execution_count": 2,
"metadata": {},
"outputs": [],
"source": [
"df = pd.read_csv('../ClinicalTrialCSV/JRCT20241129Cancer.csv', index_col=0)"
]
},
{
"cell_type": "code",
"execution_count": 6,
"metadata": {},
"outputs": [
{
"data": {
"text/html": [
"<div>\n",
"<style scoped>\n",
" .dataframe tbody tr th:only-of-type {\n",
" vertical-align: middle;\n",
" }\n",
"\n",
" .dataframe tbody tr th {\n",
" vertical-align: top;\n",
" }\n",
"\n",
" .dataframe thead th {\n",
" text-align: right;\n",
" }\n",
"</style>\n",
"<table border=\"1\" class=\"dataframe\">\n",
" <thead>\n",
" <tr style=\"text-align: right;\">\n",
" <th></th>\n",
" <th>JRCT ID</th>\n",
" <th>Title</th>\n",
" <th>Target</th>\n",
" <th>研究・治験の目的</th>\n",
" <th>試験の種類</th>\n",
" <th>無作為化</th>\n",
" <th>盲検化</th>\n",
" <th>対照</th>\n",
" <th>割付け</th>\n",
" <th>研究目的</th>\n",
" <th>...</th>\n",
" <th>purpose</th>\n",
" <th>Inclusion Criteria</th>\n",
" <th>Exclusion Criteria</th>\n",
" <th>Age Minimum</th>\n",
" <th>Age Maximum</th>\n",
" <th>Gender</th>\n",
" <th>Discontinuation Criteria</th>\n",
" <th>Keyword</th>\n",
" <th>Intervention(s)</th>\n",
" <th>Phase</th>\n",
" </tr>\n",
" </thead>\n",
" <tbody>\n",
" <tr>\n",
" <th>0</th>\n",
" <td>jRCT1030240513</td>\n",
" <td>進行がん患者に対する可聴領域外のハイレゾ自然音源が与える生体情報や癒しの変化を評価する\\n探...</td>\n",
" <td>がん</td>\n",
" <td>進行がん患者を対象に、可聴領域外のハイレゾ自然音源を介入とした音楽療法が、無音と比較して、疲...</td>\n",
" <td>介入研究</td>\n",
" <td>無作為化比較</td>\n",
" <td>単盲検</td>\n",
" <td>プラセボ対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>緩和</td>\n",
" <td>...</td>\n",
" <td>supportive care</td>\n",
" <td>Eligible participants must meet the following ...</td>\n",
" <td>Exclusion criteria apply if any of the followi...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>cancer,</td>\n",
" <td>Participants will be exposed to either sounds ...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>1</th>\n",
" <td>jRCT1032240511</td>\n",
" <td>進行がん患者の痛みに対する交番磁界治療器の至適な治療時間の条件に関する多施設共同研究</td>\n",
" <td>がん患者の疼痛</td>\n",
" <td>交番磁界治療器を用いた自宅での疼痛治療について、進行がん患者が治療の継続が可能と考える治療時...</td>\n",
" <td>介入研究</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>その他</td>\n",
" <td>...</td>\n",
" <td>other</td>\n",
" <td>1. Age 18 years or older on the day of consent...</td>\n",
" <td>1. There is a skin disorder in the painful are...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Four pads of the alternating magnetic field th...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>2</th>\n",
" <td>jRCT1032240506</td>\n",
" <td>卵巣腫瘍手術での術中低圧換気介入による術中出血量に及ぼす影響:ランダム化比較試験</td>\n",
" <td>卵巣がん</td>\n",
" <td>卵巣悪性腫瘍手術は高侵襲な手術であり輸血率の高い手術である。一方で輸血により癌の予後が悪化す...</td>\n",
" <td>介入研究</td>\n",
" <td>無作為化比較</td>\n",
" <td>単盲検</td>\n",
" <td>実薬(治療)対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>Patients undergoing ovarian cancer surgery at ...</td>\n",
" <td>1.Minors\\n\\r\\n2.Emergency surgery\\n\\r\\n3.Patie...</td>\n",
" <td>18age old over</td>\n",
" <td>100age old not</td>\n",
" <td>Female</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Low-pressure ventilation and low venous pressu...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>3</th>\n",
" <td>jRCT2041240130</td>\n",
" <td>中等度-高度PONV発症リスクを有する肺切除術予定患者の周術期管理におけるGranisetr...</td>\n",
" <td>肺がん</td>\n",
" <td>全身麻酔を要する肺切除術周術期における標準制吐療法であるグラニセトロン(Granisetro...</td>\n",
" <td>NaN</td>\n",
" <td>無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>無治療対照/標準治療対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>(1) Patients scheduled to undergo anatomical l...</td>\n",
" <td>(1) Patients with a history of allergy to the ...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Treatment group\\n\\r\\nAdminister GRA 1mg intrav...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>4</th>\n",
" <td>jRCT2031240500</td>\n",
" <td>ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する...</td>\n",
" <td>ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する...</td>\n",
" <td>固形がんは、体のさまざまな部位に発生する異常な組織の塊である。本治験は、特定の遺伝的特徴を持...</td>\n",
" <td>NaN</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>Parts 1, 2, and 3 inclusion criteria: \\n\\r\\n-H...</td>\n",
" <td>Parts 1, 2, and 3 exclusion criteria:\\n\\r\\n-Ha...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Drug: GSK4418959\\n\\r\\nDrug:PD-1 inhibitor</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>...</th>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>282</th>\n",
" <td>jRCT2080223823</td>\n",
" <td>固形がん患者を対象としたE7130 の臨床第1相試験</td>\n",
" <td>Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん</td>\n",
" <td>NaN</td>\n",
" <td>介入研究</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td><p>Both</p></td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>investigational material(s)<br>\\nGeneric name ...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>283</th>\n",
" <td>jRCT1090220266</td>\n",
" <td>肺がん手術患者に対する運動療法とBCAA摂取の併用効果の検討</td>\n",
" <td>肺がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>非盲検</td>\n",
" <td>実薬(治療)対照</td>\n",
" <td>なし</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Age Month Week Day Hour</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:BEHAVIOUR\\n\\nName of interve...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>284</th>\n",
" <td>jRCT1091220254</td>\n",
" <td>肺動静脈分離3D-CT angiographyにおけるヨード造影剤量低減の検討</td>\n",
" <td>肺がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>単盲検</td>\n",
" <td>用量比較</td>\n",
" <td>あり</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:DRUG\\n\\nName of intervention...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>285</th>\n",
" <td>jRCT1090220224</td>\n",
" <td>体幹部神経ブロック後のレボブピバカインの血中濃度の変化</td>\n",
" <td>下腹部消化器がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>非盲検</td>\n",
" <td>無対照</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>20Age Month Week Day Hour over</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:\\n\\nName of intervention:\\n\\...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>286</th>\n",
" <td>jRCT1091220221</td>\n",
" <td>ヨード造影剤と生理食塩水の混合溶液を用いたtest injectionによる混合割合と造影効...</td>\n",
" <td>肺がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>非盲検</td>\n",
" <td>無対照</td>\n",
" <td>なし</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:DRUG\\n\\nName of intervention...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" </tbody>\n",
"</table>\n",
"<p>287 rows × 35 columns</p>\n",
"</div>"
],
"text/plain": [
" JRCT ID Title \\\n",
"0 jRCT1030240513 進行がん患者に対する可聴領域外のハイレゾ自然音源が与える生体情報や癒しの変化を評価する\\n探... \n",
"1 jRCT1032240511 進行がん患者の痛みに対する交番磁界治療器の至適な治療時間の条件に関する多施設共同研究 \n",
"2 jRCT1032240506 卵巣腫瘍手術での術中低圧換気介入による術中出血量に及ぼす影響:ランダム化比較試験 \n",
"3 jRCT2041240130 中等度-高度PONV発症リスクを有する肺切除術予定患者の周術期管理におけるGranisetr... \n",
"4 jRCT2031240500 ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する... \n",
".. ... ... \n",
"282 jRCT2080223823 固形がん患者を対象としたE7130 の臨床第1相試験 \n",
"283 jRCT1090220266 肺がん手術患者に対する運動療法とBCAA摂取の併用効果の検討 \n",
"284 jRCT1091220254 肺動静脈分離3D-CT angiographyにおけるヨード造影剤量低減の検討 \n",
"285 jRCT1090220224 体幹部神経ブロック後のレボブピバカインの血中濃度の変化 \n",
"286 jRCT1091220221 ヨード造影剤と生理食塩水の混合溶液を用いたtest injectionによる混合割合と造影効... \n",
"\n",
" Target \\\n",
"0 がん \n",
"1 がん患者の疼痛 \n",
"2 卵巣がん \n",
"3 肺がん \n",
"4 ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する... \n",
".. ... \n",
"282 Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん \n",
"283 肺がん \n",
"284 肺がん \n",
"285 下腹部消化器がん \n",
"286 肺がん \n",
"\n",
" 研究・治験の目的 試験の種類 無作為化 盲検化 \\\n",
"0 進行がん患者を対象に、可聴領域外のハイレゾ自然音源を介入とした音楽療法が、無音と比較して、疲... 介入研究 無作為化比較 単盲検 \n",
"1 交番磁界治療器を用いた自宅での疼痛治療について、進行がん患者が治療の継続が可能と考える治療時... 介入研究 単一群 非盲検 \n",
"2 卵巣悪性腫瘍手術は高侵襲な手術であり輸血率の高い手術である。一方で輸血により癌の予後が悪化す... 介入研究 無作為化比較 単盲検 \n",
"3 全身麻酔を要する肺切除術周術期における標準制吐療法であるグラニセトロン(Granisetro... NaN 無作為化比較 非盲検 \n",
"4 固形がんは、体のさまざまな部位に発生する異常な組織の塊である。本治験は、特定の遺伝的特徴を持... NaN 単一群 非盲検 \n",
".. ... ... ... ... \n",
"282 NaN 介入研究 NaN NaN \n",
"283 NaN NaN NaN 非盲検 \n",
"284 NaN NaN NaN 単盲検 \n",
"285 NaN NaN NaN 非盲検 \n",
"286 NaN NaN NaN 非盲検 \n",
"\n",
" 対照 割付け 研究目的 ... purpose \\\n",
"0 プラセボ対照 並行群間比較 緩和 ... supportive care \n",
"1 非対照 単群比較 その他 ... other \n",
"2 実薬(治療)対照 並行群間比較 治療 ... treatment purpose \n",
"3 無治療対照/標準治療対照 並行群間比較 治療 ... treatment purpose \n",
"4 非対照 単群比較 治療 ... treatment purpose \n",
".. ... ... ... ... ... \n",
"282 NaN NaN NaN ... NaN \n",
"283 実薬(治療)対照 なし NaN ... NaN \n",
"284 用量比較 あり NaN ... NaN \n",
"285 無対照 NaN NaN ... NaN \n",
"286 無対照 なし NaN ... NaN \n",
"\n",
" Inclusion Criteria \\\n",
"0 Eligible participants must meet the following ... \n",
"1 1. Age 18 years or older on the day of consent... \n",
"2 Patients undergoing ovarian cancer surgery at ... \n",
"3 (1) Patients scheduled to undergo anatomical l... \n",
"4 Parts 1, 2, and 3 inclusion criteria: \\n\\r\\n-H... \n",
".. ... \n",
"282 NaN \n",
"283 NaN \n",
"284 NaN \n",
"285 NaN \n",
"286 NaN \n",
"\n",
" Exclusion Criteria \\\n",
"0 Exclusion criteria apply if any of the followi... \n",
"1 1. There is a skin disorder in the painful are... \n",
"2 1.Minors\\n\\r\\n2.Emergency surgery\\n\\r\\n3.Patie... \n",
"3 (1) Patients with a history of allergy to the ... \n",
"4 Parts 1, 2, and 3 exclusion criteria:\\n\\r\\n-Ha... \n",
".. ... \n",
"282 NaN \n",
"283 NaN \n",
"284 NaN \n",
"285 NaN \n",
"286 NaN \n",
"\n",
" Age Minimum Age Maximum \\\n",
"0 18age old over No limit \n",
"1 18age old over No limit \n",
"2 18age old over 100age old not \n",
"3 18age old over No limit \n",
"4 18age old over No limit \n",
".. ... ... \n",
"282 NaN NaN \n",
"283 Age Month Week Day Hour Age Month Week Day Hour No limit \n",
"284 Age Month Week Day Hour No limit Age Month Week Day Hour No limit \n",
"285 20Age Month Week Day Hour over Age Month Week Day Hour No limit \n",
"286 Age Month Week Day Hour No limit Age Month Week Day Hour No limit \n",
"\n",
" Gender Discontinuation Criteria Keyword \\\n",
"0 NaN NaN cancer, \n",
"1 Both NaN NaN \n",
"2 Female NaN NaN \n",
"3 Both NaN NaN \n",
"4 Both NaN NaN \n",
".. ... ... ... \n",
"282 <p>Both</p> NaN NaN \n",
"283 Both NaN NaN \n",
"284 Both NaN NaN \n",
"285 Both NaN NaN \n",
"286 Both NaN NaN \n",
"\n",
" Intervention(s) Phase \n",
"0 Participants will be exposed to either sounds ... NaN \n",
"1 Four pads of the alternating magnetic field th... NaN \n",
"2 Low-pressure ventilation and low venous pressu... NaN \n",
"3 Treatment group\\n\\r\\nAdminister GRA 1mg intrav... NaN \n",
"4 Drug: GSK4418959\\n\\r\\nDrug:PD-1 inhibitor NaN \n",
".. ... ... \n",
"282 investigational material(s)<br>\\nGeneric name ... NaN \n",
"283 Intervention type:BEHAVIOUR\\n\\nName of interve... NaN \n",
"284 Intervention type:DRUG\\n\\nName of intervention... NaN \n",
"285 Intervention type:\\n\\nName of intervention:\\n\\... NaN \n",
"286 Intervention type:DRUG\\n\\nName of intervention... NaN \n",
"\n",
"[287 rows x 35 columns]"
]
},
"execution_count": 6,
"metadata": {},
"output_type": "execute_result"
}
],
"source": [
"df"
]
},
{
"cell_type": "code",
"execution_count": 7,
"metadata": {},
"outputs": [
{
"data": {
"text/html": [
"<div>\n",
"<style scoped>\n",
" .dataframe tbody tr th:only-of-type {\n",
" vertical-align: middle;\n",
" }\n",
"\n",
" .dataframe tbody tr th {\n",
" vertical-align: top;\n",
" }\n",
"\n",
" .dataframe thead th {\n",
" text-align: right;\n",
" }\n",
"</style>\n",
"<table border=\"1\" class=\"dataframe\">\n",
" <thead>\n",
" <tr style=\"text-align: right;\">\n",
" <th></th>\n",
" <th>JRCT ID</th>\n",
" <th>Title</th>\n",
" <th>Target</th>\n",
" <th>研究・治験の目的</th>\n",
" <th>試験の種類</th>\n",
" <th>無作為化</th>\n",
" <th>盲検化</th>\n",
" <th>対照</th>\n",
" <th>割付け</th>\n",
" <th>研究目的</th>\n",
" <th>...</th>\n",
" <th>purpose</th>\n",
" <th>Inclusion Criteria</th>\n",
" <th>Exclusion Criteria</th>\n",
" <th>Age Minimum</th>\n",
" <th>Age Maximum</th>\n",
" <th>Gender</th>\n",
" <th>Discontinuation Criteria</th>\n",
" <th>Keyword</th>\n",
" <th>Intervention(s)</th>\n",
" <th>Phase</th>\n",
" </tr>\n",
" </thead>\n",
" <tbody>\n",
" <tr>\n",
" <th>3</th>\n",
" <td>jRCT2041240130</td>\n",
" <td>中等度-高度PONV発症リスクを有する肺切除術予定患者の周術期管理におけるGranisetr...</td>\n",
" <td>肺がん</td>\n",
" <td>全身麻酔を要する肺切除術周術期における標準制吐療法であるグラニセトロン(Granisetro...</td>\n",
" <td>NaN</td>\n",
" <td>無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>無治療対照/標準治療対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>(1) Patients scheduled to undergo anatomical l...</td>\n",
" <td>(1) Patients with a history of allergy to the ...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Treatment group\\n\\r\\nAdminister GRA 1mg intrav...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>4</th>\n",
" <td>jRCT2031240500</td>\n",
" <td>ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する...</td>\n",
" <td>ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する...</td>\n",
" <td>固形がんは、体のさまざまな部位に発生する異常な組織の塊である。本治験は、特定の遺伝的特徴を持...</td>\n",
" <td>NaN</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>Parts 1, 2, and 3 inclusion criteria: \\n\\r\\n-H...</td>\n",
" <td>Parts 1, 2, and 3 exclusion criteria:\\n\\r\\n-Ha...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Drug: GSK4418959\\n\\r\\nDrug:PD-1 inhibitor</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>9</th>\n",
" <td>jRCT2031240448</td>\n",
" <td>切除不能皮膚血管肉腫に対するペムブロリズマブ+レンバチニブ併用療法の第II相医師主導治験</td>\n",
" <td>切除不能皮膚血管肉腫</td>\n",
" <td>切除不能皮膚血管肉腫に対するペムブロリズマブ+レンバチニブ併用療法の有効性を検証し、有効性と...</td>\n",
" <td>NaN</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>1)\\tHistologically diagnosed with cutaneous an...</td>\n",
" <td>1)\\tPatients previously treated with anti-PD-1...</td>\n",
" <td>18age old over</td>\n",
" <td>85age old under</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>cutaneous angiosarcoma, angiosarcoma</td>\n",
" <td>Each course is set at 21 days. Pembrolizumab 2...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>12</th>\n",
" <td>jRCT2031240404</td>\n",
" <td>転移性HR+/HER2-乳がん及びその他の進行性固形がん患者を対象にCDK4阻害剤BGB-4...</td>\n",
" <td>・進行性固形腫瘍・進行性乳がん・転移性乳がん・ホルモン受容体陽性乳がん・ホルモン受容体陽性乳...</td>\n",
" <td>サイクリン依存性キナーゼ 4 (CDK4) 阻害剤である BGB-43395 が、ホルモン受...</td>\n",
" <td>NaN</td>\n",
" <td>非無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>用量比較</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>-Phase 1a (Dose Escalation) and 1b (Dose Expan...</td>\n",
" <td>-Prior therapy selectively targeting CDK4 (pri...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>-Drug: BGB-43395\\n\\r\\nPlanned doses administer...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>13</th>\n",
" <td>jRCT2031240381</td>\n",
" <td>進行固形がん患者を対象としたGSK5764227の安全性、忍容性、薬物動態、及び有効性を評価...</td>\n",
" <td>進行固形がん</td>\n",
" <td>GSK5764227の安全性、忍容性、薬物動態、及び有効性を評価する。評価する。また、GSK...</td>\n",
" <td>NaN</td>\n",
" <td>非無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>-Male or female participants at least 18 years...</td>\n",
" <td>-Has ongoing adverse reaction(s) from prior th...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Drug: GSK5764227\\n\\r\\nGSK5764227 will be admin...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>...</th>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>238</th>\n",
" <td>jRCT2033200278</td>\n",
" <td>MMG49 抗原陽性の再発・難治性多発性骨髄腫患者を対象に OPC-415 の安全性及び有効...</td>\n",
" <td>多発性骨髄腫</td>\n",
" <td>【第 I 相部分】\\r\\n• 骨髄腫細胞特異的抗体( MMG49)抗原陽性の再発・難治性のM...</td>\n",
" <td>NaN</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>-Patients aged between 20 and 80 (75 for the p...</td>\n",
" <td>-Patients who are scheduled to receive high-do...</td>\n",
" <td>20age old over</td>\n",
" <td>80age old under</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>OPC-415 (up to 1X10^7cells/kg)\\n\\r\\nOn 2 days\\...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>240</th>\n",
" <td>jRCT2051200105</td>\n",
" <td>標準化学療法に不応・不耐かつ外科的切除不能膵がん患者を対\\n象とした、 R-OKY-034F...</td>\n",
" <td>膵臓がん</td>\n",
" <td>標準化学療法に不応・不耐かつ外科的切除不能膵がん患者に対して、R-OKY-034Fを1日1回...</td>\n",
" <td>NaN</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>1. Patients who are 20 years old or above at t...</td>\n",
" <td>1. Patients with active duplicate cancer\\n\\r\\n...</td>\n",
" <td>20age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Once a day for orally\\n\\r\\n1mg/kg, 2.5mg/kg, 5...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>242</th>\n",
" <td>jRCT2071200060</td>\n",
" <td>1 種類以上の全身療法を含む 2種類以上の治療で失敗、あるいは治療中または治療後に病勢進行が...</td>\n",
" <td>頭頸部扁平上皮がん</td>\n",
" <td>1種類以上の全身療法を含む2種類以上の治療で失敗、あるいは治療中また は治療後に病勢進行した...</td>\n",
" <td>NaN</td>\n",
" <td>無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>実薬(治療)対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>Patients must meet the following criteria to b...</td>\n",
" <td>Patients with any of the following will be exc...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>ASP-1929 640mg/m^2 intravenous infusion by dri...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>257</th>\n",
" <td>jRCT2033190086</td>\n",
" <td>悪性黒色腫患者を対象としたインターロイキン12発現型遺伝子組換え単純ヘルペスウイルス1型の第...</td>\n",
" <td>悪性黒色腫</td>\n",
" <td>第Ⅰ相パート:進行期の悪性黒色腫患者を対象として、ヒトIL-12発現型遺伝子組換え単純ヘルペ...</td>\n",
" <td>NaN</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>(Phase 1)\\n\\r\\n1) Histologically confirmed mal...</td>\n",
" <td>(Phase 1 and 2)\\n\\r\\n1) Patients who have brai...</td>\n",
" <td>20age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>malignamt melanoma, advanced stage</td>\n",
" <td>Test drug (T-hIL12) will be administered into ...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>261</th>\n",
" <td>jRCT2051190009</td>\n",
" <td>進行性悪性黒色腫患者を対象としたGEN0101の皮内投与と、ペムブロリズマブ(抗PD-1抗体...</td>\n",
" <td>進行性悪性黒色腫</td>\n",
" <td>抗PD-1抗体治療でSDが確定した、またはPDとなった患者を対象とし、非盲検下でGEN010...</td>\n",
" <td>NaN</td>\n",
" <td>非無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>Inclusion criteria \\n\\r\\nPatients meeting all ...</td>\n",
" <td>Exclusion criteria\\n\\r\\nPatients meeting any o...</td>\n",
" <td>20age old over</td>\n",
" <td>86age old not</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>advanced melanoma</td>\n",
" <td>combination therapy of intracutaneous GEN0101 ...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" </tbody>\n",
"</table>\n",
"<p>124 rows × 35 columns</p>\n",
"</div>"
],
"text/plain": [
" JRCT ID Title \\\n",
"3 jRCT2041240130 中等度-高度PONV発症リスクを有する肺切除術予定患者の周術期管理におけるGranisetr... \n",
"4 jRCT2031240500 ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する... \n",
"9 jRCT2031240448 切除不能皮膚血管肉腫に対するペムブロリズマブ+レンバチニブ併用療法の第II相医師主導治験 \n",
"12 jRCT2031240404 転移性HR+/HER2-乳がん及びその他の進行性固形がん患者を対象にCDK4阻害剤BGB-4... \n",
"13 jRCT2031240381 進行固形がん患者を対象としたGSK5764227の安全性、忍容性、薬物動態、及び有効性を評価... \n",
".. ... ... \n",
"238 jRCT2033200278 MMG49 抗原陽性の再発・難治性多発性骨髄腫患者を対象に OPC-415 の安全性及び有効... \n",
"240 jRCT2051200105 標準化学療法に不応・不耐かつ外科的切除不能膵がん患者を対\\n象とした、 R-OKY-034F... \n",
"242 jRCT2071200060 1 種類以上の全身療法を含む 2種類以上の治療で失敗、あるいは治療中または治療後に病勢進行が... \n",
"257 jRCT2033190086 悪性黒色腫患者を対象としたインターロイキン12発現型遺伝子組換え単純ヘルペスウイルス1型の第... \n",
"261 jRCT2051190009 進行性悪性黒色腫患者を対象としたGEN0101の皮内投与と、ペムブロリズマブ(抗PD-1抗体... \n",
"\n",
" Target \\\n",
"3 肺がん \n",
"4 ミスマッチ修復機能欠損(dMMR)又は高頻度マイクロサテライト不安定性(MSI-H)を有する... \n",
"9 切除不能皮膚血管肉腫 \n",
"12 ・進行性固形腫瘍・進行性乳がん・転移性乳がん・ホルモン受容体陽性乳がん・ホルモン受容体陽性乳... \n",
"13 進行固形がん \n",
".. ... \n",
"238 多発性骨髄腫 \n",
"240 膵臓がん \n",
"242 頭頸部扁平上皮がん \n",
"257 悪性黒色腫 \n",
"261 進行性悪性黒色腫 \n",
"\n",
" 研究・治験の目的 試験の種類 無作為化 盲検化 \\\n",
"3 全身麻酔を要する肺切除術周術期における標準制吐療法であるグラニセトロン(Granisetro... NaN 無作為化比較 非盲検 \n",
"4 固形がんは、体のさまざまな部位に発生する異常な組織の塊である。本治験は、特定の遺伝的特徴を持... NaN 単一群 非盲検 \n",
"9 切除不能皮膚血管肉腫に対するペムブロリズマブ+レンバチニブ併用療法の有効性を検証し、有効性と... NaN 単一群 非盲検 \n",
"12 サイクリン依存性キナーゼ 4 (CDK4) 阻害剤である BGB-43395 が、ホルモン受... NaN 非無作為化比較 非盲検 \n",
"13 GSK5764227の安全性、忍容性、薬物動態、及び有効性を評価する。評価する。また、GSK... NaN 非無作為化比較 非盲検 \n",
".. ... ... ... ... \n",
"238 【第 I 相部分】\\r\\n• 骨髄腫細胞特異的抗体( MMG49)抗原陽性の再発・難治性のM... NaN 単一群 非盲検 \n",
"240 標準化学療法に不応・不耐かつ外科的切除不能膵がん患者に対して、R-OKY-034Fを1日1回... NaN 単一群 非盲検 \n",
"242 1種類以上の全身療法を含む2種類以上の治療で失敗、あるいは治療中また は治療後に病勢進行した... NaN 無作為化比較 非盲検 \n",
"257 第Ⅰ相パート:進行期の悪性黒色腫患者を対象として、ヒトIL-12発現型遺伝子組換え単純ヘルペ... NaN 単一群 非盲検 \n",
"261 抗PD-1抗体治療でSDが確定した、またはPDとなった患者を対象とし、非盲検下でGEN010... NaN 非無作為化比較 非盲検 \n",
"\n",
" 対照 割付け 研究目的 ... purpose \\\n",
"3 無治療対照/標準治療対照 並行群間比較 治療 ... treatment purpose \n",
"4 非対照 単群比較 治療 ... treatment purpose \n",
"9 非対照 単群比較 治療 ... treatment purpose \n",
"12 用量比較 単群比較 治療 ... treatment purpose \n",
"13 非対照 単群比較 治療 ... treatment purpose \n",
".. ... ... ... ... ... \n",
"238 非対照 単群比較 治療 ... treatment purpose \n",
"240 非対照 単群比較 治療 ... treatment purpose \n",
"242 実薬(治療)対照 並行群間比較 治療 ... treatment purpose \n",
"257 非対照 単群比較 治療 ... treatment purpose \n",
"261 非対照 単群比較 治療 ... treatment purpose \n",
"\n",
" Inclusion Criteria \\\n",
"3 (1) Patients scheduled to undergo anatomical l... \n",
"4 Parts 1, 2, and 3 inclusion criteria: \\n\\r\\n-H... \n",
"9 1)\\tHistologically diagnosed with cutaneous an... \n",
"12 -Phase 1a (Dose Escalation) and 1b (Dose Expan... \n",
"13 -Male or female participants at least 18 years... \n",
".. ... \n",
"238 -Patients aged between 20 and 80 (75 for the p... \n",
"240 1. Patients who are 20 years old or above at t... \n",
"242 Patients must meet the following criteria to b... \n",
"257 (Phase 1)\\n\\r\\n1) Histologically confirmed mal... \n",
"261 Inclusion criteria \\n\\r\\nPatients meeting all ... \n",
"\n",
" Exclusion Criteria Age Minimum \\\n",
"3 (1) Patients with a history of allergy to the ... 18age old over \n",
"4 Parts 1, 2, and 3 exclusion criteria:\\n\\r\\n-Ha... 18age old over \n",
"9 1)\\tPatients previously treated with anti-PD-1... 18age old over \n",
"12 -Prior therapy selectively targeting CDK4 (pri... 18age old over \n",
"13 -Has ongoing adverse reaction(s) from prior th... 18age old over \n",
".. ... ... \n",
"238 -Patients who are scheduled to receive high-do... 20age old over \n",
"240 1. Patients with active duplicate cancer\\n\\r\\n... 20age old over \n",
"242 Patients with any of the following will be exc... 18age old over \n",
"257 (Phase 1 and 2)\\n\\r\\n1) Patients who have brai... 20age old over \n",
"261 Exclusion criteria\\n\\r\\nPatients meeting any o... 20age old over \n",
"\n",
" Age Maximum Gender Discontinuation Criteria \\\n",
"3 No limit Both NaN \n",
"4 No limit Both NaN \n",
"9 85age old under Both NaN \n",
"12 No limit Both NaN \n",
"13 No limit Both NaN \n",
".. ... ... ... \n",
"238 80age old under Both NaN \n",
"240 No limit Both NaN \n",
"242 No limit Both NaN \n",
"257 No limit Both NaN \n",
"261 86age old not Both NaN \n",
"\n",
" Keyword \\\n",
"3 NaN \n",
"4 NaN \n",
"9 cutaneous angiosarcoma, angiosarcoma \n",
"12 NaN \n",
"13 NaN \n",
".. ... \n",
"238 NaN \n",
"240 NaN \n",
"242 NaN \n",
"257 malignamt melanoma, advanced stage \n",
"261 advanced melanoma \n",
"\n",
" Intervention(s) Phase \n",
"3 Treatment group\\n\\r\\nAdminister GRA 1mg intrav... NaN \n",
"4 Drug: GSK4418959\\n\\r\\nDrug:PD-1 inhibitor NaN \n",
"9 Each course is set at 21 days. Pembrolizumab 2... NaN \n",
"12 -Drug: BGB-43395\\n\\r\\nPlanned doses administer... NaN \n",
"13 Drug: GSK5764227\\n\\r\\nGSK5764227 will be admin... NaN \n",
".. ... ... \n",
"238 OPC-415 (up to 1X10^7cells/kg)\\n\\r\\nOn 2 days\\... NaN \n",
"240 Once a day for orally\\n\\r\\n1mg/kg, 2.5mg/kg, 5... NaN \n",
"242 ASP-1929 640mg/m^2 intravenous infusion by dri... NaN \n",
"257 Test drug (T-hIL12) will be administered into ... NaN \n",
"261 combination therapy of intracutaneous GEN0101 ... NaN \n",
"\n",
"[124 rows x 35 columns]"
]
},
"execution_count": 7,
"metadata": {},
"output_type": "execute_result"
}
],
"source": [
"df.dropna(subset=['試験等のフェーズ'])"
]
},
{
"cell_type": "code",
"execution_count": 8,
"metadata": {},
"outputs": [],
"source": [
"nan_rows_df = df[df['試験等のフェーズ'].isna()]"
]
},
{
"cell_type": "code",
"execution_count": 9,
"metadata": {},
"outputs": [
{
"data": {
"text/html": [
"<div>\n",
"<style scoped>\n",
" .dataframe tbody tr th:only-of-type {\n",
" vertical-align: middle;\n",
" }\n",
"\n",
" .dataframe tbody tr th {\n",
" vertical-align: top;\n",
" }\n",
"\n",
" .dataframe thead th {\n",
" text-align: right;\n",
" }\n",
"</style>\n",
"<table border=\"1\" class=\"dataframe\">\n",
" <thead>\n",
" <tr style=\"text-align: right;\">\n",
" <th></th>\n",
" <th>JRCT ID</th>\n",
" <th>Title</th>\n",
" <th>Target</th>\n",
" <th>研究・治験の目的</th>\n",
" <th>試験の種類</th>\n",
" <th>無作為化</th>\n",
" <th>盲検化</th>\n",
" <th>対照</th>\n",
" <th>割付け</th>\n",
" <th>研究目的</th>\n",
" <th>...</th>\n",
" <th>purpose</th>\n",
" <th>Inclusion Criteria</th>\n",
" <th>Exclusion Criteria</th>\n",
" <th>Age Minimum</th>\n",
" <th>Age Maximum</th>\n",
" <th>Gender</th>\n",
" <th>Discontinuation Criteria</th>\n",
" <th>Keyword</th>\n",
" <th>Intervention(s)</th>\n",
" <th>Phase</th>\n",
" </tr>\n",
" </thead>\n",
" <tbody>\n",
" <tr>\n",
" <th>0</th>\n",
" <td>jRCT1030240513</td>\n",
" <td>進行がん患者に対する可聴領域外のハイレゾ自然音源が与える生体情報や癒しの変化を評価する\\n探...</td>\n",
" <td>がん</td>\n",
" <td>進行がん患者を対象に、可聴領域外のハイレゾ自然音源を介入とした音楽療法が、無音と比較して、疲...</td>\n",
" <td>介入研究</td>\n",
" <td>無作為化比較</td>\n",
" <td>単盲検</td>\n",
" <td>プラセボ対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>緩和</td>\n",
" <td>...</td>\n",
" <td>supportive care</td>\n",
" <td>Eligible participants must meet the following ...</td>\n",
" <td>Exclusion criteria apply if any of the followi...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>cancer,</td>\n",
" <td>Participants will be exposed to either sounds ...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>1</th>\n",
" <td>jRCT1032240511</td>\n",
" <td>進行がん患者の痛みに対する交番磁界治療器の至適な治療時間の条件に関する多施設共同研究</td>\n",
" <td>がん患者の疼痛</td>\n",
" <td>交番磁界治療器を用いた自宅での疼痛治療について、進行がん患者が治療の継続が可能と考える治療時...</td>\n",
" <td>介入研究</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>その他</td>\n",
" <td>...</td>\n",
" <td>other</td>\n",
" <td>1. Age 18 years or older on the day of consent...</td>\n",
" <td>1. There is a skin disorder in the painful are...</td>\n",
" <td>18age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Four pads of the alternating magnetic field th...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>2</th>\n",
" <td>jRCT1032240506</td>\n",
" <td>卵巣腫瘍手術での術中低圧換気介入による術中出血量に及ぼす影響:ランダム化比較試験</td>\n",
" <td>卵巣がん</td>\n",
" <td>卵巣悪性腫瘍手術は高侵襲な手術であり輸血率の高い手術である。一方で輸血により癌の予後が悪化す...</td>\n",
" <td>介入研究</td>\n",
" <td>無作為化比較</td>\n",
" <td>単盲検</td>\n",
" <td>実薬(治療)対照</td>\n",
" <td>並行群間比較</td>\n",
" <td>治療</td>\n",
" <td>...</td>\n",
" <td>treatment purpose</td>\n",
" <td>Patients undergoing ovarian cancer surgery at ...</td>\n",
" <td>1.Minors\\n\\r\\n2.Emergency surgery\\n\\r\\n3.Patie...</td>\n",
" <td>18age old over</td>\n",
" <td>100age old not</td>\n",
" <td>Female</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Low-pressure ventilation and low venous pressu...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>5</th>\n",
" <td>jRCT1042240125</td>\n",
" <td>Liquid Biopsyによる膵がん早期診断法の開発</td>\n",
" <td>膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性...</td>\n",
" <td>本研究では、膵がん高危険群である膵のう胞性病変等を対象にサーベイランスプログラムを立ち上げ、...</td>\n",
" <td>観察研究</td>\n",
" <td>単一群</td>\n",
" <td>非盲検</td>\n",
" <td>非対照</td>\n",
" <td>単群比較</td>\n",
" <td>診断</td>\n",
" <td>...</td>\n",
" <td>diagnostic purpose</td>\n",
" <td>1. Cases diagnosed as high-risk group for panc...</td>\n",
" <td>1. Post-Pancreatic Surgery Cases\\n\\r\\n2. Cases...</td>\n",
" <td>20age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>6</th>\n",
" <td>jRCT1052240186</td>\n",
" <td>トリモーダルプレハビリテーションが周術期の睡眠に及ぼす影響の検討:ランダム化比較試験</td>\n",
" <td>肺がん</td>\n",
" <td>術前の介入により、介入群の方が対照群に比べて入院直後の睡眠効率が良いかどうかを検討すること</td>\n",
" <td>介入研究</td>\n",
" <td>無作為化比較</td>\n",
" <td>非盲検</td>\n",
" <td>無治療対照/標準治療対照</td>\n",
" <td>単群比較</td>\n",
" <td>予防</td>\n",
" <td>...</td>\n",
" <td>prevention purpose</td>\n",
" <td>1) Patients aged 20 and over \\n\\r\\n2) Lung can...</td>\n",
" <td>1) Patients who do not agree \\n\\r\\n2) Patients...</td>\n",
" <td>20age old over</td>\n",
" <td>No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>Malignancy</td>\n",
" <td>Intervention for the Experimental Group:\\n\\r\\n...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>...</th>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" <td>...</td>\n",
" </tr>\n",
" <tr>\n",
" <th>282</th>\n",
" <td>jRCT2080223823</td>\n",
" <td>固形がん患者を対象としたE7130 の臨床第1相試験</td>\n",
" <td>Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん</td>\n",
" <td>NaN</td>\n",
" <td>介入研究</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td><p>Both</p></td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>investigational material(s)<br>\\nGeneric name ...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>283</th>\n",
" <td>jRCT1090220266</td>\n",
" <td>肺がん手術患者に対する運動療法とBCAA摂取の併用効果の検討</td>\n",
" <td>肺がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>非盲検</td>\n",
" <td>実薬(治療)対照</td>\n",
" <td>なし</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Age Month Week Day Hour</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:BEHAVIOUR\\n\\nName of interve...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>284</th>\n",
" <td>jRCT1091220254</td>\n",
" <td>肺動静脈分離3D-CT angiographyにおけるヨード造影剤量低減の検討</td>\n",
" <td>肺がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>単盲検</td>\n",
" <td>用量比較</td>\n",
" <td>あり</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:DRUG\\n\\nName of intervention...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>285</th>\n",
" <td>jRCT1090220224</td>\n",
" <td>体幹部神経ブロック後のレボブピバカインの血中濃度の変化</td>\n",
" <td>下腹部消化器がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>非盲検</td>\n",
" <td>無対照</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>20Age Month Week Day Hour over</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:\\n\\nName of intervention:\\n\\...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" <tr>\n",
" <th>286</th>\n",
" <td>jRCT1091220221</td>\n",
" <td>ヨード造影剤と生理食塩水の混合溶液を用いたtest injectionによる混合割合と造影効...</td>\n",
" <td>肺がん</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>非盲検</td>\n",
" <td>無対照</td>\n",
" <td>なし</td>\n",
" <td>NaN</td>\n",
" <td>...</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Age Month Week Day Hour No limit</td>\n",
" <td>Both</td>\n",
" <td>NaN</td>\n",
" <td>NaN</td>\n",
" <td>Intervention type:DRUG\\n\\nName of intervention...</td>\n",
" <td>NaN</td>\n",
" </tr>\n",
" </tbody>\n",
"</table>\n",
"<p>163 rows × 35 columns</p>\n",
"</div>"
],
"text/plain": [
" JRCT ID Title \\\n",
"0 jRCT1030240513 進行がん患者に対する可聴領域外のハイレゾ自然音源が与える生体情報や癒しの変化を評価する\\n探... \n",
"1 jRCT1032240511 進行がん患者の痛みに対する交番磁界治療器の至適な治療時間の条件に関する多施設共同研究 \n",
"2 jRCT1032240506 卵巣腫瘍手術での術中低圧換気介入による術中出血量に及ぼす影響:ランダム化比較試験 \n",
"5 jRCT1042240125 Liquid Biopsyによる膵がん早期診断法の開発 \n",
"6 jRCT1052240186 トリモーダルプレハビリテーションが周術期の睡眠に及ぼす影響の検討:ランダム化比較試験 \n",
".. ... ... \n",
"282 jRCT2080223823 固形がん患者を対象としたE7130 の臨床第1相試験 \n",
"283 jRCT1090220266 肺がん手術患者に対する運動療法とBCAA摂取の併用効果の検討 \n",
"284 jRCT1091220254 肺動静脈分離3D-CT angiographyにおけるヨード造影剤量低減の検討 \n",
"285 jRCT1090220224 体幹部神経ブロック後のレボブピバカインの血中濃度の変化 \n",
"286 jRCT1091220221 ヨード造影剤と生理食塩水の混合溶液を用いたtest injectionによる混合割合と造影効... \n",
"\n",
" Target \\\n",
"0 がん \n",
"1 がん患者の疼痛 \n",
"2 卵巣がん \n",
"5 膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性... \n",
"6 肺がん \n",
".. ... \n",
"282 Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん \n",
"283 肺がん \n",
"284 肺がん \n",
"285 下腹部消化器がん \n",
"286 肺がん \n",
"\n",
" 研究・治験の目的 試験の種類 無作為化 盲検化 \\\n",
"0 進行がん患者を対象に、可聴領域外のハイレゾ自然音源を介入とした音楽療法が、無音と比較して、疲... 介入研究 無作為化比較 単盲検 \n",
"1 交番磁界治療器を用いた自宅での疼痛治療について、進行がん患者が治療の継続が可能と考える治療時... 介入研究 単一群 非盲検 \n",
"2 卵巣悪性腫瘍手術は高侵襲な手術であり輸血率の高い手術である。一方で輸血により癌の予後が悪化す... 介入研究 無作為化比較 単盲検 \n",
"5 本研究では、膵がん高危険群である膵のう胞性病変等を対象にサーベイランスプログラムを立ち上げ、... 観察研究 単一群 非盲検 \n",
"6 術前の介入により、介入群の方が対照群に比べて入院直後の睡眠効率が良いかどうかを検討すること 介入研究 無作為化比較 非盲検 \n",
".. ... ... ... ... \n",
"282 NaN 介入研究 NaN NaN \n",
"283 NaN NaN NaN 非盲検 \n",
"284 NaN NaN NaN 単盲検 \n",
"285 NaN NaN NaN 非盲検 \n",
"286 NaN NaN NaN 非盲検 \n",
"\n",
" 対照 割付け 研究目的 ... purpose \\\n",
"0 プラセボ対照 並行群間比較 緩和 ... supportive care \n",
"1 非対照 単群比較 その他 ... other \n",
"2 実薬(治療)対照 並行群間比較 治療 ... treatment purpose \n",
"5 非対照 単群比較 診断 ... diagnostic purpose \n",
"6 無治療対照/標準治療対照 単群比較 予防 ... prevention purpose \n",
".. ... ... ... ... ... \n",
"282 NaN NaN NaN ... NaN \n",
"283 実薬(治療)対照 なし NaN ... NaN \n",
"284 用量比較 あり NaN ... NaN \n",
"285 無対照 NaN NaN ... NaN \n",
"286 無対照 なし NaN ... NaN \n",
"\n",
" Inclusion Criteria \\\n",
"0 Eligible participants must meet the following ... \n",
"1 1. Age 18 years or older on the day of consent... \n",
"2 Patients undergoing ovarian cancer surgery at ... \n",
"5 1. Cases diagnosed as high-risk group for panc... \n",
"6 1) Patients aged 20 and over \\n\\r\\n2) Lung can... \n",
".. ... \n",
"282 NaN \n",
"283 NaN \n",
"284 NaN \n",
"285 NaN \n",
"286 NaN \n",
"\n",
" Exclusion Criteria \\\n",
"0 Exclusion criteria apply if any of the followi... \n",
"1 1. There is a skin disorder in the painful are... \n",
"2 1.Minors\\n\\r\\n2.Emergency surgery\\n\\r\\n3.Patie... \n",
"5 1. Post-Pancreatic Surgery Cases\\n\\r\\n2. Cases... \n",
"6 1) Patients who do not agree \\n\\r\\n2) Patients... \n",
".. ... \n",
"282 NaN \n",
"283 NaN \n",
"284 NaN \n",
"285 NaN \n",
"286 NaN \n",
"\n",
" Age Minimum Age Maximum \\\n",
"0 18age old over No limit \n",
"1 18age old over No limit \n",
"2 18age old over 100age old not \n",
"5 20age old over No limit \n",
"6 20age old over No limit \n",
".. ... ... \n",
"282 NaN NaN \n",
"283 Age Month Week Day Hour Age Month Week Day Hour No limit \n",
"284 Age Month Week Day Hour No limit Age Month Week Day Hour No limit \n",
"285 20Age Month Week Day Hour over Age Month Week Day Hour No limit \n",
"286 Age Month Week Day Hour No limit Age Month Week Day Hour No limit \n",
"\n",
" Gender Discontinuation Criteria Keyword \\\n",
"0 NaN NaN cancer, \n",
"1 Both NaN NaN \n",
"2 Female NaN NaN \n",
"5 Both NaN NaN \n",
"6 Both NaN Malignancy \n",
".. ... ... ... \n",
"282 <p>Both</p> NaN NaN \n",
"283 Both NaN NaN \n",
"284 Both NaN NaN \n",
"285 Both NaN NaN \n",
"286 Both NaN NaN \n",
"\n",
" Intervention(s) Phase \n",
"0 Participants will be exposed to either sounds ... NaN \n",
"1 Four pads of the alternating magnetic field th... NaN \n",
"2 Low-pressure ventilation and low venous pressu... NaN \n",
"5 NaN NaN \n",
"6 Intervention for the Experimental Group:\\n\\r\\n... NaN \n",
".. ... ... \n",
"282 investigational material(s)<br>\\nGeneric name ... NaN \n",
"283 Intervention type:BEHAVIOUR\\n\\nName of interve... NaN \n",
"284 Intervention type:DRUG\\n\\nName of intervention... NaN \n",
"285 Intervention type:\\n\\nName of intervention:\\n\\... NaN \n",
"286 Intervention type:DRUG\\n\\nName of intervention... NaN \n",
"\n",
"[163 rows x 35 columns]"
]
},
"execution_count": 9,
"metadata": {},
"output_type": "execute_result"
}
],
"source": [
"nan_rows_df"
]
},
{
"cell_type": "code",
"execution_count": null,
"metadata": {},
"outputs": [],
"source": []
}
],
"metadata": {
"kernelspec": {
"display_name": "gradio",
"language": "python",
"name": "python3"
},
"language_info": {
"codemirror_mode": {
"name": "ipython",
"version": 3
},
"file_extension": ".py",
"mimetype": "text/x-python",
"name": "python",
"nbconvert_exporter": "python",
"pygments_lexer": "ipython3",
"version": "3.12.3"
}
},
"nbformat": 4,
"nbformat_minor": 2
}
|